当前位置: 首页 > 期刊 > 《中国药房》 > 2025年第15期
编号:2440081
黄葵胶囊联合环磷酰胺及泼尼松治疗肾功能不全IgA肾病的临床观察
http://www.100md.com 2025年9月2日 中国药房 2025年第15期
    

    中图分类号 R969.4;R692.3+1 文献标志码A 文章编号 1001-0408(2025)15-1899-05

    DOI 10.6039/j.issn.1001-0408.2025.15.14

    Clinical observation of Huangkui capsule combined with cyclophosphamide and prednisone in the treatment of IgA nephropathy with renal insufficiency

    JIANG Yan, ZHANG Ming,LIU Guoxin, ZHAO Chenyang(Dept. of Pharmacy,the Second Afiliated Hospita ofDalian Medical University,Liaoning Dalian 116021,China)

    ABSTRACTOBJECTIVEToexplore theclinicaleficacyandsafetyofHuangkuicapsulecombinedwithcyclophosphamide and prednisone inthetreatmentofimmunoglobulinA(IgA)nephropathywithrenalinsuffciency.METHODSAtotalof117patients withIgAnephropathyandrenalinsuficiencywhowerehospitalizedinthedepartmentofnephrologyoftheSecondAfiliated HospitalofDalianMedicalUniversityfromFebruary 2021toMarch 2024were dividedintoprednisonegroup( n=38 ), cyclophosphamide group ( n=39 )and Huangkui group( n=40 )according to the random number table method.On the basis of standardized basic treatment ......

您现在查看是摘要页,全文长 18890 字符